Bumetanide Injection — FDA Drug Shortage

Current — MSN Laboratories Private Limited

The FDA lists a drug shortage record for Bumetanide Injection (injection) from MSN Laboratories Private Limited with status Current. The shortage was first posted on 12/13/2017.

Shortage Details

Status
Current
Company
MSN Laboratories Private Limited
Package NDC
72205-102-01
Dosage Form
Injection
Presentation
Bumetanide, Injection, 0.25 mg/mL, 10 mL (NDC 72205-102-01)
Initial Posting
12/13/2017
Revised Date